Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Frontiers in Immunology|January 1, 2026
Metabolic reprogramming as a therapeutic target for modulating the Th17/Treg balance in autoimmune diseases: a comprehensive reviewYuehong Hu, Qihan Zhao, Haoran Dai, et al.International Immunopharmacology|August 4, 2024
B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challengesYadi Wu, Hanxue Jiang, Yuehong Hu, et al.Experimental Gerontology|December 2, 2023
Experimental models for elderly patients with membranous nephropathy: Application and advancementsXinyue Tang, Haoran Dai, Yuehong Hu, et al.Frontiers in Nutrition|November 4, 2021
Association Between Diet-Related Inflammation and COPD: Findings From NHANES IIIHaiyue Liu, Xilan Tan, Zuheng Liu, et al.Journal of Translational Autoimmunity|January 6, 2025
IL-12 family cytokines and autoimmune diseases: A potential therapeutic target?Xiaoyu Cui, Wu Liu, Hanxue Jiang, et al.International Immunopharmacology|December 3, 2022
Cytokines network in primary membranous nephropathyQihan Zhao, Haoran Dai, Yuehong Hu, et al.Interactive Cardiovascular and Thoracic Surgery|September 10, 2020
Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control studyYuehong Hu, Xiaoqian Li, Haixia Zhou, et al.Cancer Letters|December 20, 2014
MicroRNAs in colorectal cancer: small molecules with big functionsYu Xuan, Huiliang Yang, Linjie Zhao, et al.Frontiers in Pharmacology|March 16, 2023
Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathyXiaoshan Zhou, Haoran Dai, Hanxue Jiang, et al.Frontiers in Immunology|August 19, 2022
Level of interleukin-35 in patients with idiopathic membranous nephropathy and its predictive value for remission timeNa Zhang, Haoran Dai, Xuan Dong, et al.Pageof 3